Yu Zhen, Li Zeng-Jun, Yi Shu-Hua, Zhou Ke-Shu, Hao Mu, Qi Jun-Yuan, Li Chang-Hong, Qiu Lu-Gui
State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin 300020, China.
Zhonghua Xue Ye Xue Za Zhi. 2011 Aug;32(8):529-32.
To investigate the overrepresentation of specific gene segments of immunoglobulin heavy chain variable region (IgVH) among unmutated and mutated chronic lymphocytic leukemia (CLL) patients and its prognostic implication.
Multiplex PCR was used to identify the expression of IgVH segment and its mutation status in CLL.
Analyses were successfully performed in 80 of 85 samples. Marked skewed IgVH families were disclosed. The most commonly used VH was VH3 (40.0%), followed by VH4 (30.0%), VHI (13.8%), VH2 (10.0%) and VH5, VH7 (2.5%). Fifty-six patients (70.0%) had mutated VH, 24 (30.0%) unmutated VH. Nine cases (11.3%) were with 100% germline sequence. Fifteen cases (15/24, 62.5%) in VH4, 29 (29/32, 90.7%) in VH3, and 4 (4/11, 36.3%) in VH1 had mutated VH. The most frequently used IgVH gene was VH4-39 (13.8%), and VH4-34 (8.8%). J4 (36/66, 54.5%) and D3 (25/66, 37.8%) were the most frequently used in J and D genes. The progression-free survival (PFS) was 82 and 17 months (P = 0.000), and the overall survival (OS) was 90 and 41 months (P = 0.009), respectively, for mutated and unmutated cases. Recurrent CDR3 sequences were found in our patients and 2 patients with VH1-69 had CDR3 sequences highly similar to those reported in literature.
There is difference in IgVH gene segment usage and mutational status in different area CLL patients. Recurrent CDR3 sequences were found in specific IgVH gene segments, which highlights the importance of immunoglobulin mediated stimulation in the development of CLL.
研究免疫球蛋白重链可变区(IgVH)特定基因片段在未突变和突变的慢性淋巴细胞白血病(CLL)患者中的过度表达及其预后意义。
采用多重聚合酶链反应(Multiplex PCR)鉴定CLL中IgVH片段的表达及其突变状态。
85份样本中的80份成功进行了分析。发现了明显偏态的IgVH家族。最常用的VH是VH3(40.0%),其次是VH4(30.0%)、VHI(13.8%)、VH2(10.0%)以及VH5、VH7(2.5%)。56例患者(70.0%)VH发生突变,24例(30.0%)VH未突变。9例(11.3%)具有完全胚系序列。VH4中有15例(15/24,62.5%)、VH3中有29例(29/32,90.7%)、VH1中有4例(4/11,36.3%)VH发生突变。最常用的IgVH基因是VH4-39(13.8%)和VH4-34(8.8%)。J4(36/66,54.5%)和D3(25/66,37.8%)是J和D基因中最常用的。突变和未突变病例的无进展生存期(PFS)分别为82个月和17个月(P = 0.000),总生存期(OS)分别为90个月和41个月(P = 0.009)。在我们的患者中发现了复发的互补决定区3(CDR3)序列,2例VH1-69患者的CDR3序列与文献报道的高度相似。
不同地区CLL患者在IgVH基因片段使用和突变状态方面存在差异。在特定的IgVH基因片段中发现了复发的CDR3序列,这突出了免疫球蛋白介导的刺激在CLL发生发展中的重要性。